Copernicus Therapeutics

company

About

Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology
Number Of Employee
1 - 10
Operating Status
Active

Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company and a leader in the emerging field of precision medicine and gene therapy. Through their proprietary, non-viral, nucleic acid nanoparticle platform, they are able to achieve robust gene transfer in several tissues without the immune response and limited treatment window of AAV.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$6.60M
Copernicus Therapeutics has raised a total of $6.60M in funding over 2 rounds. Their latest funding was raised on Jun 30, 2008 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 30, 2008 Grant 1 Ohio Department of Development Detail
Nov 20, 2002 Series Unknown $2M 1 Veron International Detail
Jan 1, 1999 Series Unknown $4.60M 1 Biotechnology Development Fund VI, L.P. Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Copernicus Therapeutics is funded by 3 investors. Ohio Department of Development and Veron International are the most recent investors.
Investor Name Lead Investor Funding Round
Ohio Department of Development Yes Grant
Veron International Yes Series Unknown
Biotechnology Development Fund VI, L.P. Yes Series Unknown